LRLucia Rangel-Gamboa

Lucia Rangel-Gamboa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lucia Rangel-Gamboa has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Transmission risk of Trypanosoma cruzi through blood donors in a third-level care hospital

    by Viridiana Gonzalez-Lopez, Carlos Alberto Zuñiga-Cruz, Sahara Vázquez-Ramírez, Emilio Rendon-Franco, Guiehdani Villalobos, Lucia Rangel-Gamboa, Fernando Martinez-Hernandez

    Blood transfusion is a major way of Trypanosoma cruzi transmission, a neglected parasite infection that produces Chagas disease (CD). CD has high morbidity and is potentially fatal in the chronic phase due to the parasite’s ability to invade the myocardium, colon, and esophagus. CD prevalence focuses on Latin America; however, its presence in non-endemic areas has been increasing in the last decade, particularly in North America and Europe, due to high migration rates of infected people. This study established the CD seroprevalence in a blood bank located in Mexico City. A total of 851 donor samples were analyzed by ELISAn and Western blotn (ELISA and WB using native antigens obtained from Mexican strains). Positive samples were analyzed by a commercial ELISA kit, named Chagatest (non-native antigens). Average donor age was 36.5 years, and most were men. Seroprevalence by ELISAn and WBn was 3.9% (33/851); whereas by Chagatest only six samples (0.7%) were reactive. Mexico City is not considered an endemic CD area; however, the high mobility of infected people increases the transmission risk in all receptor areas, particularly in blood banks, as seen in this study. Our findings showed a difference between native and non-native serological tests, and the need to maximize the identification of infected people to curb CD spread.


  • Eumycetoma: present status and perspective

    by Roberto Arenas-Guzmán, Marí­a Elisa Vega-Memije, Lucía Rangel-Gamboa

  • Open Access

    Frontal fibrosing alopecia, clinical and histopathological characteristics of mexican patients: an original research study and review of literature

    by Munoz-Camacho Marcela, Lucía Rangel-Gamboa, Vega Memije, María Elisa, Rangel-Gamboa Lucia

    Background: Frontal Fibrosing Alopecia (FFA) was described at twenty-century, and cases increased exponentially. FFA has a great impact on patient’s quality life. Objective: Thus, the aim of this work was report FFA cases attended during a fifteen-year period. Material and methods: A retrospective study was carried out, including patients with FFA diagnosis treated at Dermatology department. Data were obtained from the clinical files, and tissue slices were reviewed. Results: Thirty-seven patients FFA were identified. Ninety-seven percent (n= 36) were women, with an average age of 57.8 years (range between 35 to 86 years). Eighty-one percent presented with recession of implantation line as the main clinical manifestation; the predominant histological pattern was scarring alopecia, presented in 34 patients (91.8%). Discussion: Increased of the pathology was observed in the last five years, since 2017. FFA is a newly diagnosed disease with increased prevalence in Mexico, where it occurs predominantly in postmenopausal women. Conclusion: Mexican patients presented in late stages of the disease, with mean ages lower than other series, so in our country the challenge is to identify the FFA in early stage and prevent disease progression and the irreversible alopecia.

  • Open Access

    Trypanosoma cruzi DTU II coinfection with bacteria producing prolonged cutaneous lesion in a healthy young male

    by Lucia Rangel-Gamboa, Erik-Iyair González-Martínez, Lizbeth Cristina Sánchez-Cruz, Ana Isabel Montiel-Rangel, Fernando Martínez-Hernández

    Chagas disease (CD) is a neglected tropical disease caused by Trypanosoma cruzi and is genetically classified in six discrete typing units (DTUs). The isolates reported in Mexico are generally associated with DTU I. We presented a case of a prolonged cutaneous lesion in a Mexican man, caused by DTU II in coinfection with Bacillus velezensis and Corynebacterium sp. The patient assessment included a complete clinical history, physical exam, laboratory tests, and a skin biopsy. In the facial tissues, intracellular parasites were revealed. The PCR tests were positive for T. cruzi in tissue and blood samples. DNA satellite sequencing was correlated with the DTU II. The initial serological tests reported negative results. However, four months later, two serological tests reported positive results. These exams were performed in different health centers. Mexico is considered an endemic area for CD; nevertheless, this is just the second cutaneous case associated with a DTU different from DTU-I noted in this country. From an ecological point of view, this fact suggests a geographical expansion of DTU II and an association with atypical skin manifestations. Further studies should be conducted to understand this exciting association between DTU-II and prolonged cutaneous expression in humans.


  • Open Access

    Utility of IgG4 immunohistochemistry detection in pemphigus diagnosis

    by Maricela García-Lechuga, María Elisa Vega-Memije, Ana Isabel Montiel-Rangel, Andres Torres-González, Lucia Rangel-Gamboa

    Pemphigus includes a group of blistering autoimmune diseases that affect the skin and mucosa, characterized by the formation of epidermal bullous and the presence of antibodies against binding proteins. Pemphigus is classified according to clinical presentation, target molecule, and IgG production as pemphigus vulgaris, foliaceous, IgA-pemphigus, and paraneoplastic pemphigus. Thus, the identification of autoantibodies class and site of deposition is mandatory. The gold standard to identify the immune complex deposition is the direct immunofluorescences technique, performed in fresh tissue; unfortunately, this method is unavailable in the regional hospital at the Mexican provinces. Nevertheless, IgG subclass-4 is the prevalence of immunoglobulin in acantholysis. Therefore, this IgG subclass could be detected using IgG4 immunohistochemistry. Because direct immunofluorescences technique is absent in provinces or patients denied a new biopsy to confirm the diagnosis, this work presented pemphigus vulgaris confirmation using the IgG4 immunohistochemistry technique in patients with clinical lesions suggestive of pemphigus vulgaris and intraepidermal blister manifestation in histopathology.


  • Open Access

    Cutaneous manifestations of COVID-19 in Mexican patients: A case series and review of literature

    by Juan Carlos Palomo-Pérez, Maria Elisa Vega-Memije, David Aguilar-Blancas, Erik González-Martínez, Lucia Rangel-Gamboa

    China officially recognized atypical pneumonia outbreak in December 2019; on 11 March 2020, the World Health Organization declared COVID-19 as a pandemic that is produced by a new coronavirus, named SARS-CoV-2, of rapid transmissibility, which can be asymptomatic, with mild to severe respiratory symptoms, and with cardiovascular, neurological, gastrointestinal, and cutaneous complications. Considering that the pandemic prolonged more than initially expected was prognostic, it is essential for the medical community to identify the signs and symptoms of COVID-19. Thus, this work’s objectives were to present cases of cutaneous lesions observed in COVID-19 Mexican patients. We register cutaneous lesions in COVID-19 patients referred from internal medicine and otorhinolaryngology services to dermatology. We presented four interesting cases with cutaneous lesions, including exanthema morbilliform, urticaria, chilblains, ecchymosis, and facial edema, and review the available literature. The most frequent cutaneous markers are rash, chilblains, and urticaria. Skin lesions may be the first manifestation of COVID-19, accompany initial respiratory symptoms, or appear during the disease course. Symptoms associated with vascular changes (livedo reticularis and vasculitis) are considered of poor prognosis.


  • Open Access

    Trypanosoma cruzi infection associated with atypical clinical manifestation during the acute phase of the Chagas disease

    by Lucia Rangel-Gamboa, Lirio López-García, Francisco Moreno-Sánchez, Irma Hoyo-Ulloa, María Elisa Vega-Mémije, Nancy Mendoza-Bazán, Mirza Romero-Valdovinos, Angélica Olivo-Díaz, Guiehdani Villalobos, Fernando Martínez-Hernández

    Background: Chagas disease (CD) is caused by the protozoan parasite Trypanosoma cruzi and is transmitted by triatomine insects. Clinical manifestations vary according to the phase of the disease. Cutaneous manifestations are usually observed in the acute phase (chagoma and Romaña’s sign) or after reactivation of the chronic phase by immunosuppression; however, a disseminated infection in the acute phase without immunosuppression has not been reported for CD. Here, we report an unusual case of disseminated cutaneous infection during the acute phase of CD in a Mexican woman. Methods: Evaluation of the patient included a complete clinical history, a physical exam, and an exhaustive evaluation by laboratory tests, including ELISA, Western blot and PCR. Results: Skin biopsies of a 50-year-old female revealed intracellular parasites affecting the lower extremities with lymphangitic spread in both legs. The PCR tests evaluated biopsy samples obtained from the lesions and blood samples, which showed a positive diagnosis for T. cruzi. Partial sequencing of the small subunit ribosomal DNA correlated with the genetic variant DTU II; however, serological tests were negative. Conclusions: We present a case of CD with disseminated skin lesions that was detected by PCR and showed negative serological results. In Mexico, an endemic CD area, there are no records of this type of manifestation, which demonstrates the ability of the parasite to initiate and maintain infections in atypical tissues.


  • A population genetics analysis in clinical isolates of Sporothrix schenckii based on calmodulin and calcium/calmodulin‐dependent kinase partial gene sequences

    by Lucia Rangel‐Gamboa, Fernando Martinez‐Hernandez, Pablo Maravilla, Ana Flisser

    Summary: Sporotrichosis is a subcutaneous mycosis that is caused by diverse species of Sporothrix. High levels of genetic diversity in Sporothrix isolates have been reported, but few population genetics analyses have been documented. To analyse the genetic variability and population genetics relations of Sporothrix schenckii Mexican clinical isolates and to compare them with other reported isolates. We studied the partial sequences of calmodulin and calcium/calmodulin‐dependent kinase genes in 24 isolates; 22 from Mexico, one from Colombia, and one ATCC®6331™; the latter was used as a positive control. In total, 24 isolates were analysed. Phylogenetic, haplotype and population genetic analyses were performed with 24 sequences obtained by us and 345 sequences obtained from GenBank. The frequency of S. schenckii sensu stricto was 81% in the 22 Mexican isolates, while the remaining 19% were Sporothrix globosa. Mexican S. schenckii sensu stricto had high genetic diversity and was related to isolates from South America. In contrast, S. globosa showed one haplotype related to isolates from Asia, Brazil, Spain and the USA. In S. schenckii sensu stricto, S. brasiliensis and S. globosa, haplotype polymorphism (θ) values were higher than the nucleotide diversity data (π). In addition, Tajima's D plus Fu and Li's tests analyses displayed negative values, suggesting directional selection and arguing against the model of neutral evolution in these populations. In addition, analyses showed that calcium/calmodulin‐dependent kinase was a suitable genetic marker to discriminate between common Sporothrix species.


  • Etiología de las vasculitis cutáneas: utilidad de una aproximación sistémica

    by Caroline Chanussot-Deprez, Marí­a Elisa Vega-Memije, Luis Flores-Suárez, Celia Ríos-Romero, Javier Cabiedes-Contreras, Edgardo Reyes, Lucía Rangel-Gamboa

    Cutaneous vasculities (CV) represents a diagnostic challenge, occurs as primary cutaneous disorder or as a manifestation of other entities. Objective: To search the cause of CV. Methods: Patients with CV were prospectively evaluated. In all patients, skin biopsies were drawn, and direct immunofluorescence was done in most of the patients. American College of Rheumatology (ACR) and Chapel Hill Consensus Conference Criteria (CHCC) were used for classification. Results: 32 patients were studied. There was female predominance (71.8%). Children presented drug-associated CV or Schonlein-Henoch purpura (SHP). Adults presented more frequently SHP, systemic lupus erythematosus or paraneoplastic vasculitis, other diagnosis as polyarteritis nodosa, microscopic polyangiitis, thrombotic vasculitis (post-puerperal), antiphospholipid syndrome, Churg-Strauss syndrome, and drug-associated CV were presented. Using the ACR and CHCC criteria, 50% of cases were classified. Discussion: In our institution, during this work the etiologic diagnostic of CV increased more than twice. However, in the case of HSV or LA and SHP none of the proposed criteria had high specificity other parameters were used to discern between both. Six patients remained as not classified. In our view, cryoglobulins and hepatitis serology do not seem useful unless patient's history supports they need to be done. Unclassified patients were followed-up closely for 2 years.


  • Eumicetoma: actualidades y perspectivas

    by Roberto Arenas-Guzmán, Marí­a Elisa Vega-Memije, Lucía Rangel-Gamboa

    The eumycetoma is a severely debilitating chronic progressive fungal cutaneous infection. Classic clinical triad is characterized by painless subcutaneous mass, sinus tracts formation and sero-purulent discharge that contain aggregates of fungal hyphae called grains. Any part of the body can have affected, with extension to muscular or bone, even visceral compromised. The eumycetoma is observed in tropical and subtropical countries; In Latin-America, is reported with less frequency. In endemic areas, antibody presence again etiological agents were higher compared with number of people affected, thus it is supposed that individual genetic susceptibility most by exist. Recently, it was reported specific polymorphism in genes CR1, IL-8, NOS2 and chitriosidase, which were associated with development of eumycetoma. The diagnosis is suggested by clinical presentation; the histopathology and microbiology studies, plus radiologic valuation confirmed diagnosis. Madurella mycetomatis is the most informed etiological agent. Using phylogenetic tools new species in genus Madurella were reported; moreover, Trematosphaeria grisea and Pseudallescheria boydii were reclassified. Etiological agent Identification is important, because differences in antifungal susceptibility exist. Eumycetoma treatment includes surgery plus antifungal drugs. Identification of etiological agents is primordial, because antifungal resistance could exist. To development new pharmacological strategies, comprehension of grain formation physiology and drugs effects are necessary.